In a changing environment, flexibility and adaptability are key attributes for CDMOs to successfully provide cold-chain and fill/finish capabilities for mRNA vaccine production. Hear from Jinhyeok Jeong, Head of our Inspection & Packaging Team, who shares his perspective on the strategies and tactics it takes to deliver a better drug development program.
In a changing environment, flexibility and adaptability are key attributes for CDMOs to successfully provide cold-chain and fill/finish capabilities for mRNA vaccine production. Hear from Jinhyeok Jeong, Head of our Inspection & Packaging Team, who shares his perspective on the strategies and tactics it takes to deliver a better drug development program.
- CDO
- CGMP
- ADC
- Bio Campus
- IR
- CMO
Share article